| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 10/23/2001 | CA2047496C Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 10/18/2001 | WO2001077109A2 Sodium salt of an azo derivative of 5-aminosalicylic acid |
| 10/18/2001 | WO2001077105A1 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof |
| 10/18/2001 | WO2001077104A1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 10/18/2001 | WO2001077101A1 Chemical compounds |
| 10/18/2001 | WO2001077100A2 Benzoamide piperidine compounds as substance p antagonists |
| 10/18/2001 | WO2001077073A1 Cathepsin cysteine protease inhibitors |
| 10/18/2001 | WO2001076693A1 Inhibitors of prenyl-protein transferase |
| 10/18/2001 | WO2001027087A3 Process for making boc-protected 3-aminohydantoins/thiohydantoins and 3-aminodihydrouracils/dihydrothiouracils |
| 10/18/2001 | WO2001025213B1 Pyrrolo imidazole derivatives and their use as medicaments |
| 10/18/2001 | US20010031765 Antiviral compounds |
| 10/18/2001 | US20010031761 Compounds such as camptothecin 20-o-nonanoate; antitumor agents; low toxicity; good absorbability |
| 10/18/2001 | US20010031759 Novel heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases |
| 10/18/2001 | US20010031758 Administering compounds such as 4-(2-(2-(4-methoxyphenyl) ethylamino)ethyl)amino-2-methyl-9-(2-,4,6-trimethylphenyl)-9h-pyridino(2,3 -b)indole as neuropeptide y receptor antagonists to treat feeding disorders, etc |
| 10/18/2001 | DE10011608A1 Bis-o-aminophenole und o-Aminophenolcarbonsäuren Bis-o-aminophenols and o-aminophenolcarboxylic acids |
| 10/18/2001 | CA2405089A1 Benzoamide piperidine containing compounds and related compounds |
| 10/18/2001 | CA2404630A1 Cathepsin cysteine protease inhibitors |
| 10/18/2001 | CA2403012A1 Chemical compounds |
| 10/17/2001 | EP1144411A1 Antihistaminic spiro compounds |
| 10/17/2001 | EP1144410A2 Use of imidazo 1,5-a]-pyrido 3,2-e]-pyrazinones as medicaments |
| 10/17/2001 | EP1144409A2 Phenyl urea and phenyl thiourea derivatives |
| 10/17/2001 | EP1144404A1 Piperidinylquinolines as protein tyrosine kinase inhibitors |
| 10/17/2001 | EP1144403A1 Substitued pyrazoles as p38 kinase inhibitors |
| 10/17/2001 | EP1144387A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
| 10/17/2001 | EP1143991A2 Inhibitors of h+k+ -atpase |
| 10/17/2001 | EP1001955B1 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them |
| 10/17/2001 | EP0833818B1 3-acylindoles as cb2 receptor agonists |
| 10/17/2001 | EP0652871B1 Benzodiazepine derivatives |
| 10/17/2001 | EP0554434B1 Imaging of infections |
| 10/17/2001 | CN1318067A Compounds, compsns. and methods for stimulating neuronal growth and elongation |
| 10/17/2001 | CN1318066A Process for prodn. of naphthyridine carboxylic acid derivative (methanesulfonate sesquihydrate) |
| 10/17/2001 | CN1073112C Possibly substituted 8-cyano-cyclopropyl-7-(2,8-diazabicyclo-[4,3,0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives |
| 10/17/2001 | CN1073111C Process for preparation of 2,3-pyridinedicarboximides |
| 10/17/2001 | CN1073110C Process for prep. of biphenyl derivatives |
| 10/16/2001 | US6303814 N-[1,2,4]triazoloazinyl) benzenesulfonamide and pyridinesulfonamide compounds and their use as herbicides |
| 10/16/2001 | US6303633 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 10/16/2001 | US6303625 Triazolopyridines for the treatment of thrombosis disorders |
| 10/16/2001 | US6303624 Preventives and remedies for hyperphosphatemia |
| 10/16/2001 | US6303614 Tetrahydro gamma-carbolines |
| 10/16/2001 | US6303613 As nitric oxide synthase inhibitor useful in therapy or prophylaxis of inflammatory disease and pain |
| 10/16/2001 | US6303609 Used for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders |
| 10/16/2001 | US6303603 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors |
| 10/16/2001 | US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 10/16/2001 | US6303593 For therapy human immunodeficiency virus infection, aquired immunodeficiency syndrome (aids), inflammatory and immunoregulatory disorder or disease, asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis |
| 10/16/2001 | CA2044796C Process for producing pyrido[1,2-a] pyrimidine derivative |
| 10/16/2001 | CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase |
| 10/11/2001 | WO2001074816A1 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents |
| 10/11/2001 | WO2001074815A2 Phenyl-substituted imidazopyridines |
| 10/11/2001 | WO2001074814A1 Phenyl-substituted indolizine derivatives and their use as histamine h3 ligands |
| 10/11/2001 | WO2001074813A2 METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS |
| 10/11/2001 | WO2001074810A2 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists |
| 10/11/2001 | WO2001074791A1 Diazepane derivatives or salts thereof |
| 10/11/2001 | WO2001074790A2 Novel compounds for enhancing chemotherapy |
| 10/11/2001 | WO2001074788A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 10/11/2001 | WO2001074773A2 Phenyl-substituted indoles as histamine h3-receptor antagonists |
| 10/11/2001 | WO2001074391A1 Preventives/remedies for kidney diseases |
| 10/11/2001 | WO2001027119A3 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines |
| 10/11/2001 | WO2001017998A3 Method for the production of substituted pyrimidine derivatives |
| 10/11/2001 | US20010029298 Novel intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| 10/11/2001 | US20010029237 A bicyclic triazole or diazole containing sulfonyl or phosphine oxide or thiophosphorus derivatives; useful as bactericide and fungicide in crop protection |
| 10/11/2001 | CA2405132A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 10/11/2001 | CA2404665A1 Novel compounds for enhancing chemotherapy |
| 10/11/2001 | CA2400057A1 4-oxo-1,4-dihydro¬1,8|naphthyridine-3-carboxamides as antiviral agents |
| 10/10/2001 | EP1142892A1 Processes for the preparation of novel naphthyridine derivatives |
| 10/10/2001 | EP1142587A1 Remedies for pain |
| 10/10/2001 | EP1141140A1 Naphthalenehydrazamimides and perylenehydrazamimides |
| 10/10/2001 | EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response |
| 10/10/2001 | EP1140948A1 Camptothecin analogs and methods of preparation thereof |
| 10/10/2001 | EP1140941A1 Nitrogen containing heterobicycles as factor xa inhibitors |
| 10/10/2001 | EP1140936A1 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 10/10/2001 | EP1140935A2 1,2-annelated quinoline derivatives |
| 10/10/2001 | EP1140934A1 BENZISOXAZOLES AND PHENONES AS $g(a) 2?-ANTAGONISTS |
| 10/10/2001 | EP1140933A2 Process for preparing n6-substituted deaza-adenosine derivatives |
| 10/10/2001 | EP1140932A1 1,8-benzonaphthyridine derivatives |
| 10/10/2001 | EP1140931A1 5ht1 antagonists for antidepressant therapy |
| 10/10/2001 | EP1140930A1 DIBENZO a,g]QUINOLIZINIUM DERIVATIVES AND THE SALTS THEREOF |
| 10/10/2001 | EP1140929A1 1h-imidazo 4,5-d]pyridazin-7-ones, 3h-imidazo 4,5-c]pyridin-4-ones and corresponding thiones as corticotropin releasing factor (crf) receptor ligands |
| 10/10/2001 | EP1140924A1 Piperazine derivatives |
| 10/10/2001 | EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
| 10/10/2001 | EP1140871A1 Thrombin or factor xa inhibitors |
| 10/10/2001 | EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 10/10/2001 | EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors |
| 10/10/2001 | EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 10/10/2001 | EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 10/10/2001 | EP1140768A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases |
| 10/10/2001 | EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 10/10/2001 | EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 10/10/2001 | EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia |
| 10/10/2001 | EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 10/10/2001 | EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 10/10/2001 | EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 10/10/2001 | EP1140099A1 Utilisation of 2-substituted 1,2-benzisothiazole derivatives and 3-substituted tetrahydropyridopyrimidinone derivatives for the prophylaxis and therapy of cerebral ischaemia |
| 10/10/2001 | EP1140097A2 Products comprising trihydroxystilbenes and derivatives thereof and methods for their manufacture and use |
| 10/10/2001 | EP1140092A2 Method of treating sexual disturbances |
| 10/10/2001 | EP1140091A2 Formulations comprising imiquimod or other immune response modifiers for treating mucosal consitions |
| 10/10/2001 | EP1140090A1 Use of phanquinone for the treatment or prevention of memory impairment |
| 10/10/2001 | EP1140087A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 10/10/2001 | EP1140086A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |